Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
about
Oxidative Stress Signaling in Alzheimers DiseaseAmyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's diseaseNovel therapeutics for Alzheimer's disease: an updateMechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylationGenetic variability of respiratory complex abundance, organization and activity in mouse brainCrystallization and preliminary X-ray diffraction data for the aconitase form of human iron-regulatory protein 1.Effect of metals on kinetic pathways of amyloid-β aggregationMitochondrial mechanisms of estrogen neuroprotection.Challenges associated with metal chelation therapy in Alzheimer's diseaseCauses versus effects: the increasing complexities of Alzheimer's disease pathogenesis.Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging.Involvement of oxidative stress in Alzheimer disease.The impact of human and mouse differences in NOS2 gene expression on the brain's redox and immune environment.Iron: A Pathological Mediator of Alzheimer Disease?Frontiers in Alzheimer's disease therapeutics.Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis.Aging-related gene expression in hippocampus proper compared with dentate gyrus is selectively associated with metabolic syndrome variables in rhesus monkeys.Curcumin inhibits appoptosin-induced apoptosis via upregulating heme oxygenase-1 expression in SH-SY5Y cellsCortical iron regulation and inflammatory response in Alzheimer's disease and APPSWE/PS1ΔE9 mice: a histological perspectiveLack of extracellular superoxide dismutase (EC-SOD) in the microenvironment impacts radiation-induced changes in neurogenesisMetal-protein attenuating compounds and Alzheimer's disease.Sphingomyelin SM(d18:1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-β42, tau, and phospho-tau-181 levels.Novel mechanisms for estrogen-induced neuroprotection.Mitoenergetic failure in Alzheimer disease.Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress.Altered APP Carboxyl-Terminal Processing Under Ferrous Iron Treatment in PC12 Cells.MicroRNAs (miRNAs) in neurodegenerative diseases.Sublethal RNA oxidation as a mechanism for neurodegenerative diseaseInterleukin-1beta: a bridge between inflammation and excitotoxicity?Estrogen actions on mitochondria--physiological and pathological implications.Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.The genomic response of the ipsilateral and contralateral cortex to stroke in aged rats.Aging, circadian rhythms and depressive disorders: a review.Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches.JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities.Oxidative damage to RNA in aging and neurodegenerative disorders.Cognitive impairment, genomic instability and trace elements.Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer's diseaseGlutathione Conformations and Its Implications for in vivo Magnetic Resonance Spectroscopy.The effect of iron in MRI and transverse relaxation of amyloid-beta plaques in Alzheimer's disease
P2860
Q22241327-734B30AA-007C-4CDD-A07A-E404FB802E5CQ24305330-5C69EBC1-59CA-4A67-AFC7-B30D6E133E01Q24620383-6FF80B64-CE21-4808-981C-D118E12DEA64Q26830954-BA599DCF-DE5F-4E2C-A664-80797358950DQ28397261-73AAE59D-EEBA-42B9-866D-1E97261A3550Q33235195-6C749446-6FB1-422F-BA67-19F90A56C9EBQ33649803-3B3C3D48-1B2A-4E29-87B8-82F826992A9DQ33927797-BE2DADC5-516F-4696-A2D7-C6E26162EE6DQ34099450-34D11C56-8B2A-40D1-A6A3-6AAF09D1ACFCQ34112184-8932F5D9-6C53-45C4-8C68-0A5D30EFFB21Q34379668-90DD7452-538A-407F-8D96-7F45E086BE8BQ34545547-914450E5-C09B-45DB-81FC-07DA0FEED2D8Q34584761-BBC6714B-3A5E-490F-9124-E60925433826Q34894011-D422A6D9-0B05-4483-9BE3-D96513C90F2AQ35086876-9F1C13A0-4662-440B-949E-D78F4F898445Q35143061-DA63F5B7-89D8-4BA0-8CBE-478C6C74405FQ35161815-C3446B25-CBF2-461A-86D4-8E4F8D1186B7Q35578526-3F1EB214-8C43-4804-A4B0-51927B9068E9Q35880679-7849A845-D73C-4656-BEE0-589E1A4EBA83Q35915960-1CD95869-A5AA-4899-A8D7-D0392D29CCEEQ35964717-90767C09-ABD1-4483-8FF7-A9AB7AD9773FQ36424510-64042DA3-ABB5-4E1E-AA97-9506E7B38F2BQ36459049-8BD9BCAE-28AE-46E3-9BBF-989A410B1DDCQ36522646-AA1D1138-BAC6-42DC-A704-B4988C3A075BQ36576454-83C32ADF-0FF4-4C6D-8745-06CD9CA1D033Q36927531-49BC437C-ADB3-4DAD-ABD5-F71E27734B47Q37069478-8A0D3CFA-29FA-457C-AA09-8DC434B63A38Q37083453-801A0A05-993F-417A-8556-0424DC5683BFQ37100241-64D89D71-E29C-4524-B7D9-4F2F81AB3B0FQ37197561-A22CC0FE-DED5-4678-89E2-1CD8461AF6E9Q37262124-FA98D5CB-A226-46F3-95EF-DF1FBAE12E30Q37310708-B1E50CE1-C8BA-4B81-BAEC-9D960F98E0E9Q37366995-BCC5EADA-C76F-4396-AF80-3802BE850BDBQ37462278-28AF45A9-6DD7-46B0-A988-1CFAE2A4BD4BQ37793978-131A8017-7EDC-46EC-9E6C-5850AB12D6D0Q38016374-35BC9BC7-2BB5-4645-B7C9-F28C47633440Q38308233-77F76C1C-5EFB-4F19-9F61-91F57EAC2A21Q38331188-A7A62274-7CB0-4816-B8D6-54990D4013B6Q41102891-7CAB5FC9-5662-413B-AD2F-92D07320FF21Q41661825-487D7DA1-FB29-4314-B655-E4FD7DF78468
P2860
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
@ast
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
@en
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
@nl
type
label
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
@ast
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
@en
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
@nl
prefLabel
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
@ast
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
@en
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
@nl
P2093
P1476
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
@en
P2093
P304
P356
10.1089/15230860050192198
P50
P577
2000-01-01T00:00:00Z